Announced today:

Accelerator Corporation, a privately held, venture capital backed biotechnology investment and development company, announced today the Series A Preferred Stock financing of Acylin Therapeutics, Inc. … The investors participating in the Series A investment in Acylin included Accelerator syndicate partners: Alexandria Real Estate Equities; Amgen Ventures; ARCH Venture Partners, Inc.; OVP Venture Partners; PPD, Inc.; and WRF Capital.

via Accelerator Corporation Finances Eleventh Startup with Acylin Therapeutics, Inc. – MarketWatch.

Tagged with →  
Share →